Puma Biotech Priced Like Cougar Stokes Deal Optimism

Puma Biotech Priced Like Cougar Stokes Deal Optimism

Tim Shaffer/Bloomberg

AstraZeneca Plc sells the cancer drugs Iressa and Zoladex. The company, facing the loss of patent protection by the end of 2014 for drugs producing more than 40 percent of its sales, has experienced repeated setbacks in developing new products.